Agilent

Agilent

Diegem, Belgium· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Agilent Technologies' mission is to deliver trusted answers and insights through its comprehensive portfolio of analytical instrumentation, software, and services. The company has achieved a dominant position in chromatography, mass spectrometry, and nucleic acid solutions, underpinned by a strong heritage in precision measurement from its HP origins. Its strategy focuses on integrating hardware, software, and consumables into high-value workflow solutions, driving recurring revenue through its Agilent CrossLab services while expanding in high-growth areas like genomics, diagnostics, and biopharmaceutical QA/QC.

OncologyGenetic DisordersInfectious Disease

Technology Platform

Agilent's platform is a comprehensive ecosystem of measurement science technologies, including market-leading chromatography, mass spectrometry, genomics tools, clinical diagnostics instruments, and integrated software informatics, designed to provide complete workflow solutions for life science research and clinical analysis.

Opportunities

Agilent is poised to benefit from sustained growth in biopharmaceutical innovation (e.g., cell & gene therapies, ADCs), the global expansion of precision medicine requiring advanced diagnostics, and the increasing need for laboratory productivity solutions, which drive demand for its integrated instrument, software, and service offerings.

Risk Factors

Key risks include sensitivity to macroeconomic cycles impacting capital equipment spending, intense competition from larger and more diversified rivals, significant revenue concentration in geopolitically sensitive regions like China, and the potential for technological disruption in its core markets.

Competitive Landscape

Agilent competes with giants like Thermo Fisher Scientific and Danaher, as well as focused players like Waters and Bruker. Its competitive advantages are instrument reliability, a fully integrated portfolio, and a strong direct service network, though it must continually innovate against rivals with greater scale in R&D and manufacturing.